You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
A randomized, double-blind, placebo-controlled, Phase I/II trial of RNActive®-vaccine cv9104 in patients with metastatic castrate-refractory prostate cancer (mcrpc): first results of the Phase I part
|
|---|---|
| Published in |
Journal for Immunotherapy of Cancer, November 2014
|
| DOI | 10.1186/2051-1426-2-s3-p85 |
| Authors |
Sven D Koch, Henoch Hong, Susan Feyerabend, Margitta Retz, Hubert Kuebler, Axel Heidenreich, Thomas van Erps, Andreas Schroeder, Birgit Scheel, Valérie Reus, Karl-Josef Kallen, Mariola Fotin-Mleczek, Ulrike Gnad-Vogt, Arnulf Stenzl |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Madagascar | 1 | 20% |
| Unknown | 4 | 80% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 15 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 3 | 20% |
| Student > Bachelor | 2 | 13% |
| Student > Postgraduate | 2 | 13% |
| Lecturer | 1 | 7% |
| Student > Master | 1 | 7% |
| Other | 3 | 20% |
| Unknown | 3 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 3 | 20% |
| Agricultural and Biological Sciences | 2 | 13% |
| Immunology and Microbiology | 2 | 13% |
| Economics, Econometrics and Finance | 1 | 7% |
| Nursing and Health Professions | 1 | 7% |
| Other | 0 | 0% |
| Unknown | 6 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 April 2024.
All research outputs
#4,846,803
of 25,712,965 outputs
Outputs from Journal for Immunotherapy of Cancer
#1,249
of 3,493 outputs
Outputs of similar age
#52,200
of 277,184 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#9
of 65 outputs
Altmetric has tracked 25,712,965 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,493 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.6. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 277,184 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 65 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.